TO THE EDITOR
We read with interest the article entitled ''IGF-1 signalling controls the hair growth cycle and the differentiation of hair shafts '' (Weger and Schlake, 2005) .
Recently, we have reported documentation of the role of primary IGF-1 deficiency on hair structure in human beings (Lurie et al., 2004) . Laron syndrome is a recessively inherited disease of primary IGF-1 deficiency owing to primary growth hormone insensitivity. Affected children have sparse hair growth and frontal recessions. The hair is thin and easy to pluck, and young adults have various degrees of alopecia. Despite signs of early aging, graying of the hair is delayed and reduced (Laron, 2004) . The syndrome is caused by deletions or mutations in the growth hormone receptor or postreceptor pathways, which lead to an inability to generate IGF-1 (Laron, 2002 (Laron, , 2004 . We investigated the effect of primary IGF-1 deficiency on hair structure by sampling the hair of 11 patients with Laron syndrome. The most significant structured defect, pili torti et canaliculi, was found in two young, untreated patients. Grooving, tapered hair, and trichorrhexis nodosa were found in the remainder. IGF-1-treated patients had either none or significantly fewer pathological changes compared to the untreated patients.
We believe our report (Lurie et al., 2004) Whereas IGF-I has been initially described as a potent mitogen supporting cell growth and survival (Stewart and Rotwein, 1996) , there is accumulating evidence for its participation in diverse differentiation processes (Musaro and Rosenthal, 1999; Hsieh et al., 2004) . Our recent work on IGF-I confirmed this dual role for the murine hair follicle (Weger and Schlake, 2005a, b) . In man, an IGF-I deficiency is associated with Laron syndrome (Laron, 2002 TO THE EDITOR The erythrokeratodermas (EKs) include a clinically and genetically heterogeneous group of disorders characterized by erythematous and hyperkeratotic lesions, either stationary or migratory. Two major subtypes have been defined: erythrokeratodermia variabilis (EKV, OMIM 133200) and progressive symmetric erythrokeratodermia (PSEK, OMIM 602036). PSEK is characterized by fixed erythematous keratotic plaques distributing symmetrically over the body, particularly on the extremities, the buttocks, and the faces, sometimes together with palmoplantar keratoderma. Two sisters have been described, in which the younger one suffering EKV whereas the older one suffering PSEK, and this report brought forward the hypothesis that PSEK and EKV were different manifestations of a single conditions (MacFarlane et al., 1991) . However, accumulating genetic studies supported the distinct molecular pathology underlying them (Richard et al., 1998 (Richard et al., , 2002 (Richard et al., , 2003 . The major clinical feature distinguishing between PSEK and EKV is the sharply outlined geographical regions of migratory erythema in the latter (Ishida-Yamamoto et al., 1997) , and parakeratosis is an evident pathological feature in PSEK and usually not seen in EKV. Furthermore, ichthyotic variant of Vohwinkel syndrome, KID syndrome, and some transgradient forms of palmoplantar keratoderma should also be differentiated from PSEK based on the clinical and histological characteristics. The pathologic mechanism of PSEK is still unknown. No loci for PSEK have been defined by genetic linkage analysis up to date. A frameshift mutation (709insC) in the loricrin gene (OMIM #152445) on chromosome 1q21 has been identified in a Japanese PSEK family with generalized, well-demarcated erythematous hyperkeratotic plaques and mutilating palmoplantar keratoderma (pseudoainhum) (IshidaYamamoto et al., 1997). Loricrin is a major structural component of the crosslinked cell envelope of the epidermis, which participates in the formation of keratohyalin granules (Hohl et al., 1991; Candi et al., 1995) , and the responsibility of the loricrin gene for variant form of Vohwinkel syndrome has been demonstrated (Maestrini et al., 1996) . Some authors considered the Japanese pedigree mentioned above affecting variant form of Vohwinkel syndrome rather than PSEK, because pseudoainhum was usually not seen in PSEK, and the location of above mutation was only 21 bp upstream to that of Vohwinkel syndrome variant form (730insG) (Richard et al., 2002) . Our previous study has excluded the loricrin gene is the responsibility gene for PSEK (Cui et al., 2004) .
To map the disease locus of PSEK, we carried out a genome-wide scan in a five-generation Chinese PSEK family consisting of 27 individuals. There are 12 affected individuals in this family,
